MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-29-2023
Chembio Diagnostics ROA Ratio 2011-2025 | CEMI
Annual ROA Ratio Chembio Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -37.2 | -46.28 | -39.33 | -24.54 | -19.23 | -38.35 | -64.87 | -11.52 | -4.55 | 2.17 | 5.43 | 40.09 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 40.09 | -64.87 | -19.85 |
Quarterly ROA Ratio Chembio Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -38.73 | -46.3 | -29.13 | -47.41 | -33.7 | -42.23 | -43.19 | -37.0 | -28.33 | -35.12 | -33.37 | -27.0 | -17.56 | -23.22 | -22.09 | -20.59 | -11.48 | -23.5 | -21.37 | -30.22 | -38.35 | -38.75 | -45.62 | -73.12 | -64.87 | -55.56 | -47.26 | -9.88 | -11.52 | -9.48 | -8.46 | -5.86 | -2.56 | 0.36 | 4.37 | 3.97 | 3.24 | 1.55 | -3.06 | -0.3 | 2.59 | 5.66 | 10.42 | 9.9 | 3.41 | 3.07 | 1.26 | -0.92 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 10.42 | -73.12 | -20.36 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Brainsway Ltd.
BWAY
|
-8.53 | $ 19.33 | 0.21 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 20.97 | -1.38 % | $ 226 M |  China |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M |  USA |
 |
Co-Diagnostics
CODX
|
-37.07 | $ 0.23 | -4.4 % | $ 6.75 M | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
3.43 | $ 39.53 | -1.4 % | $ 1.1 B | USA |
 |
BioNano Genomics
BNGO
|
-146.1 | $ 1.52 | - | $ 1.93 M | USA |
 |
DarioHealth Corp.
DRIO
|
-61.65 | $ 10.17 | 1.29 % | $ 289 M | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
DexCom
DXCM
|
8.64 | $ 67.51 | 0.13 % | $ 26.1 B | USA |
 |
Danaher Corporation
DHR
|
5.03 | $ 230.0 | -0.45 % | $ 168 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-14.58 | $ 101.56 | 0.02 % | $ 18.8 B | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 26.78 | -0.85 % | $ 810 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-40.76 | $ 19.47 | -1.32 % | $ 1.05 B | USA |
 |
Celcuity
CELC
|
-45.6 | $ 101.9 | -0.7 % | $ 4.02 B | USA |
 |
Anixa Biosciences
ANIX
|
-58.14 | $ 3.21 | -6.25 % | $ 102 K | USA |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
5.1 | $ 226.52 | 0.26 % | $ 41.1 B | USA |
 |
Guardant Health
GH
|
-29.37 | $ 103.35 | 0.94 % | $ 12.7 B | USA |
 |
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
-12.39 | $ 6.44 | -1.68 % | $ 583 M | USA |
 |
Illumina
ILMN
|
-19.4 | $ 135.12 | -0.15 % | $ 21.5 B | USA |
 |
Charles River Laboratories International
CRL
|
0.29 | $ 203.88 | - | $ 10.5 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-258.47 | $ 4.94 | -3.14 % | $ 2.65 M | USA |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 7.12 | -0.35 % | $ 1.54 B | USA |
 |
National Research Corporation
NRC
|
25.3 | $ 18.74 | 0.46 % | $ 460 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.39 | $ 176.16 | 0.15 % | $ 19.6 B | USA |
|
Biodesix
BDSX
|
-44.15 | $ 6.76 | -0.88 % | $ 877 M | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
4.06 | $ 254.32 | 0.02 % | $ 21.3 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 182.75 | -0.51 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
26.96 | $ 688.22 | 0.01 % | $ 56.8 B | USA |
 |
Pacific Biosciences of California
PACB
|
-17.57 | $ 1.77 | -5.85 % | $ 449 M | USA |
 |
Lantheus Holdings
LNTH
|
15.78 | $ 66.73 | 0.07 % | $ 4.62 B | USA |
 |
Mettler-Toledo International
MTD
|
26.64 | $ 1 419.64 | 0.11 % | $ 30.1 B |  Schweiz |
 |
Agilent Technologies
A
|
11.3 | $ 138.31 | 0.03 % | $ 42 B | USA |
 |
Biomerica
BMRA
|
-83.65 | $ 2.7 | 1.9 % | $ 6.2 M | USA |
 |
Bioventus
BVS
|
-19.27 | $ 7.4 | 0.27 % | $ 464 M | USA |
 |
NeoGenomics
NEO
|
-4.81 | $ 12.33 | 0.2 % | $ 1.56 B | USA |